BridgeBio Oncology Therapeutics, Inc.（BBOT）内部人交易：高管与董事近期交易
过去 18 个月，共有 11 位内部人为 BridgeBio Oncology Therapeutics, Inc.（BBOT）报告了 33 笔 Form 4 交易（最近一笔 2026-10-05）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-05 | Cobo Marc | Principal Accounting Officer | 卖出 | 126 | $496 |
| 2026-10-05 | Ben Yong | Chief Med & Dev Officer | 卖出 | 1,047 | $4,125 |
| 2026-10-05 | Beltran Pedro | President and CEO | 卖出 | 1,047 | $4,125 |
| 2026-10-05 | Elmelech Idan | COO & Principal Financial Ofcr | 卖出 | 343 | $1,351 |
| 2026-09-14 | Cobo Marc | Principal Accounting Officer | 买入 | 9,038 | $0 |
| 2026-09-14 | Cobo Marc | Principal Accounting Officer | 卖出 | 203 | $1,121 |
| 2026-07-06 | Chen Bihua | 董事 | 买入 | 1.7M | $0 |
| 2026-07-06 | Cobo Marc | Principal Accounting Officer | 卖出 | 125 | $975 |
| 2026-07-06 | Ben Yong | Chief Med & Dev Officer | 卖出 | 1,047 | $8,167 |
| 2026-07-06 | Beltran Pedro | President and CEO | 卖出 | 1,047 | $8,167 |
| 2026-07-06 | Elmelech Idan | COO & Principal Financial Ofcr | 卖出 | 343 | $2,675 |
| 2026-07-06 | Chen Bihua | 董事 | 买入 | 2.7M | $0 |
| 2026-07-06 | Chen Bihua | 董事 | 卖出 | 4.5M | $0 |
| 2026-07-06 | Chen Bihua | 董事 | 买入 | 130,865 | $0 |
| 2026-05-05 | Ben Yong | Chief Med & Dev Officer | 卖出 | 1,047 | $9,454 |
| 2026-05-05 | Beltran Pedro | President and CEO | 卖出 | 1,047 | $9,454 |
| 2026-05-05 | Mehra Uneek | 内部人 | 卖出 | 524 | $4,732 |
| 2026-03-12 | Beltran Pedro | Chief Scientific Officer | 买入 | 46,670 | $0 |
| 2026-03-12 | Mehra Uneek | Chief Financial Officer | 买入 | 23,330 | $0 |
| 2026-03-12 | Ben Yong | Chief Med & Dev Officer | 买入 | 46,670 | $0 |
| 2025-10-16 | BridgeBio Pharma, Inc. | 10% 以上股东 | 买入 | 784,720 | $0 |
| 2025-10-16 | BridgeBio Pharma LLC | 10% 以上股东 | 买入 | 784,720 | $0 |
| 2025-08-13 | Chen Bihua | 董事 | 买入 | 4.2M | $0 |
| 2025-08-13 | Chen Bihua | 董事 | 卖出 | 152,940 | $0 |
| 2025-08-13 | Chen Bihua | 董事 | 买入 | 760,496 | $8.2M |
来源：SEC Form 4 申报文件 · 截至 2026-10-05